Si-Quat by AFFIX Labs (FI)
- Funded by European Commission
- Total publications:244 publications
Grant number: Unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$238,021.3Funder
European CommissionPrincipal Investigator
.Research Location
N/A
Research Priority Alignment
N/A
Research Category
Infection prevention and control
Research Subcategory
Barriers, PPE, environmental, animal and vector control measures
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Innovation: Si-Quat is an anti-viral clear coat developed to kill viruses including the pathogen of COVID-19. The coating is able to resist thousands of touches and creates an active layer that is self-sanitizing within minutes. Expected Results: Si-Quat active coating has been developed and tested in the lab. In the coming months SiQuat will be field tested and rolled out commercially. The greater goal of the product is to help communities re-open and make people feel more confident going out working, shopping and dining.
Publicationslinked via Europe PMC
Last Updated:4 days ago
View all publications at Europe PMC